Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Adding vs Switching in Postmenopausal Osteoporosis
NCT00079924Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in postmenopausal osteoporosis, sponsored by Eli Lilly and Company. Started Nov 2004; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00079924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079924.